Εμφανίζονται 1 - 20 Αποτελέσματα από 108 για την αναζήτηση '"ДЕЙСТВЕННОСТЬ"', χρόνος αναζήτησης: 1,13δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Academic Journal

    Πηγή: Economic development and analysis; Vol. 1 No. 8 (2023): Economic development and analysis; 20-26 ; Экономическое развитие и анализ; Том 1 № 8 (2023): Экономическое развитие и анализ; 20-26 ; Iqtisodiy taraqqiyot va tahlil; Jild 1 № 8 (2023): Iqtisodiy taraqqiyot va tahlil; 20-26 ; 2992-877X ; 10.60078/2992-877X-2023-vol1-iss8

    Περιγραφή αρχείου: application/pdf

  6. 6
  7. 7
  8. 8
    Conference

    Συγγραφείς: Хасанова, И. И.

    Περιγραφή αρχείου: application/pdf

    Relation: Образование в Уральском регионе: научные основы развития и инноваций : материалы IV региональной научно-практической конференции. — Екатеринбург, 2006

    Διαθεσιμότητα: https://elar.uspu.ru/handle/ru-uspu/37015

  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
    Academic Journal

    Πηγή: Regulatory Research and Medicine Evaluation; № 1 (2015); 40-44 ; Регуляторные исследования и экспертиза лекарственных средств; № 1 (2015); 40-44 ; 3034-3453 ; 3034-3062 ; undefined

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.vedomostincesmp.ru/jour/article/view/26/10; Garrido M.V., Kristensen F.B., Nielsen C.P., et al. Оценка медицинских технологий и формирование политики здравоохранения в странах Европы. ВОЗ; 2010.; Хабриев Р.У., Ягудина Р.И., Правдюк Н.Г. Оценка технологий здравоохранения. М.: Медицинское информационное агентство; 2013.; Белоусов Ю.Б., ред. Оценка медицинских технологий. М.: ОКИ; 2013.; Kleijnen S., George E., Goulden S., et al. Relative Effectiveness Assessment of Pharmaceuticals: Similarities and Differences in 29 Jurisdictions. Value In Health 2012; (15): 954-60.; High Level Pharmaceutical Forum. Core principles on relative effectiveness. 2008.; Available from: http://www.inahta.net.; Wagner P., Srivastava S. New paradigms in translational science research in cancer biomarkers. Translational Research 2012; (4): 343-53.; Gartlehner G., Hansen R., Nissman D., et al. A simple and valid tool distinguished efficacy from effectiveness studies. Journal of Clinical Epidemiology 2006; (10): 1040-48.; Singal A., Higgins P., Waljee A. A Primer on Effectiveness and Efficacy Trials. Clinical and Translational Gastroenterology 2014; (5): 1-4.; Marchand E., Stice E., Rohde P., et al. Moving from efficacy to effectiveness trials in prevention research. Behaviour Research and Therapy 2011; (1): 32-41.; Behnke L.M., Solis A., Shulman S.A., et al. Targeted Approach to Reducing Overutilization: Use of Percutaneous Coronary Intervention in Stable Coronary Artery Disease. Popul Health Manag. 2013; 16(3): 164-8.; Stafford R.S., Radley D.C. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003; (41): 56-61.; Hingwala J., Diamond J., Tangri N., et al. Underutilization of peritoneal dialysis: the role of the nephrologist's referral pattern. Nephrol Dial Transplant. 2013; 28(3): 732-40.; Lenfant C. Clinical Research to Clinical Practice - Lost in Translation? N Engl J Med. 2003; (349): 868-74.; Kessler R., Glasgow R.E. A proposal to speed translation of healthcare research into practice: dramatic change is needed. Am J Prev Med. 2011; 40(6): 637644.; Zwarenstein M., Treweek S., Gagnier J.J., et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008; 337: a2390.; Sox H.C. Defining comparative effectiveness research: the importance of getting it right. Med Care 2010; 48 [6 Suppl]: S7-8.; Hoagwood K., Hibbs E., Brent D., Jensen P. Introduction to the special section: efficacy and effectiveness in studies of child and adolescent psychotherapy. Journal of Consulting and Clinical Psychology 1995; (63): 683-87.; Gaglio B., Phillips S., Heurtin-Roberts S., et al. How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research. Implementation Science 2014; (9): 96.; Keramaris N., Kanakaris N., Tzioupis C., et al. Translational research: From bench-side to bedside. Injury 2008; (6): 643-50.; Westfall J.M., Mold J., Fagnan L. Practice-based research - "Blue Highways" on the NIH roadmap. Journal of the American Medical Association 2007; 297(4): 403-6.; Balas E.A., Boren S.A. Yearbook of Medical Informatics. Schattauer Verlagsgesellschaft mbH. Managing Clincial Knowledge for Healthcare Improvement. Stuttgart; 2000.; Contopoulos-Ioannidis D.G., Alexiou G.A., Gouvias T.C., et al. Life cycle of translational research for medical interventions. Science 2008; 321(5894): 1298-9.; Trochim W., Kane C., Graham M.J., et al. Evaluating translational research: a process marker model. Clin Transl Sci. 2011; 4(3): 153-62.; Westfall J.M., Mold J., Fagnan L. Practice-based research - ''blue highways'' on the NIH roadmap. JAMA 2007; (297): 403-6.; Dougherty D., Conway P.H. The ''3T's'' road map to transform US health care: the ''how'' of high-quality care. JAMA 2008; (299): 2319-21.; Drolet B., Lorenzi N. Translational research: understanding the continuum from bench to bedside. Translational Research 2011; (1): 1-5.; Khoury M.J., Gwinn M., Yoon P.W., et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genetics in Medicine 2007; 9(10): 665-74.; Sung N.S., Crowley W.F. Jr, Genel M., et al. Central challenges facing the national clinical research enterprise. JAMA 2003; (289): 1278-87.; Cao Y. Antiangiogenic cancer therapy: why do mouse and human patients respond in a different way to the same drug? The International Journal of Developmental Biology 2011; (55): 557-62.; Wehling M. Assessing the translatability of drug projects: what needs to be scored to predict success? Nat Rev Drug Discov 2009; (8): 541-46.; Wang P., Heinssen R., Oliveri M., et al. Bridging Bench and Practice: Translational Research for Schizophrenia and Other Psychotic Disorders. Neuropsychopharmacology 2009; (34): 204-12.; Schumacher A., Rujan T., Hoefkens J. A collaborative approach to develop a multiomics data analytics platform for translational research. Appl Transl Genomic. Available from: http://dx.doi.org/10.1016/j.atg.2014.09.010.; Yao Q., Lyu P., Ma F., el al. Global infometric perspective studies on translational medical research. BMC Medical informatics and Decision Making 2013; (13): 77.; Grunseth M., Chen C., Cook S., et al. Surveying the best in translation. Nature Biotechnology 2014; 32(5): 415-18.; Отчет о проведении всероссийской научной школы «Трансляционная медицина: международный опыт и тенденции развития в России». Москва. 3 ноября 2011.; Available from: http://www.almazovcentre.ru/?page_id=10962.; Kent D.M., Alsheikh-Ali A., Hayward R.A. Competing risk and heterogeneity of treatment effect in clinical trials. Trials 2008, (9): 30.; Available from: http://www.re-aim.hnfe.vt.edu/forms/reaim_framework_constructs_checklist.pdf; https://www.vedomostincesmp.ru/jour/article/view/26; undefined

  20. 20